The present studies demonstrated a decreased degree of α2,6-sialylation of AGP N-glycans in the group of patients with severe COVID-19 compared to the healthy control group, and an increased degree of α2,6-sialylation in the group of convalescents compared to the control group and COVID-19 patients as well. This evidence concerns the gene ATP5MK and COVID-19.